Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2209)	1/6/2010 3:35:17 PM
From: Jibacoa	Read Replies (2) of 3722

AFFX seems to have found support at the $6 level in spite of its recent "downgrades".<g> bigcharts.marketwatch.com In the 3rdQ it reported 4% better revenues and was able to trim some its loss. But for the YR it is still expected to have a loss around $0.48 vs. $0.33 in 2008 and fro 2010 the loss is still projected around $0.15 The stock still could close some of the DG of Oct22 above the $8 level. But at the $8 level I am looking to buy some AMRI in spite of its losses in the last 3Qs.<g> AMRI is trading below BV and has +CF and the SR which has increased lately is around 11.2x its ADV.If the EE are correct it is supposed to report on the black next Yr. for a 460% improvement on the bottom line<g> AFFX has a good size LTD, trades around 1.4xBV and has smaller +CF Recently AFFX has been performing better lately. finance.yahoo.com^ixic;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined But from a longer term view, AMRI has been more consistent.<g> finance.yahoo.com^ixic;indicator=volume;charttype Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next